Pacira BioSciences Ownership 2024 | Who Owns Pacira BioSciences Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

112.19%

Insider Ownership

2.03%

Retail Ownership

-14.22%

Institutional Holders

283.00

Pacira BioSciences Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.17.34%0.01%8,006,826101,6701.29%229,075,292Jun 30, 2024
VANGUARD GROUP INC11.01%0.00%5,084,831-28,553-0.56%145,477,014Jun 30, 2024
PACER ADVISORS, INC.4.68%0.14%2,162,787590,08237.52%61,877,336Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC4.47%0.10%2,066,197184,0009.78%59,113,896Jun 30, 2024
STATE STREET CORP4.12%0.00%1,903,8502380.01%54,469,149,000Jun 30, 2024
FRONTIER CAPITAL MANAGEMENT CO LLC3.98%0.52%1,836,873-77,470-4.05%52,552,940Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP3.96%0.01%1,828,065198,93612.21%52,299,570Jun 30, 2024
MACQUARIE GROUP LTD3.39%0.05%1,567,0135,9740.38%44,832,000Jun 30, 2024
STEPHENS INVESTMENT MANAGEMENT GROUP LLC2.97%0.55%1,371,561-55,184-3.87%39,240,360Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC2.36%0.00%1,089,30452,6235.08%31,171,537Jun 30, 2024
DOMA PERPETUAL CAPITAL MANAGEMENT LLC2.17%13.28%1,000,761275,12637.92%28,631,772Jun 30, 2024
RICE HALL JAMES & ASSOCIATES, LLC2.16%1.71%998,625-44,915-4.30%28,570,661Jun 30, 2024
MARSHALL WACE, LLP2.10%0.04%971,143159,79119.69%27,784,403Jun 30, 2024
BAILLIE GIFFORD & CO1.75%0.02%806,097-194,677-19.45%23,062,435Jun 30, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP1.70%0.68%785,000-270,500-25.63%22,458,850Jun 30, 2024
NUVEEN ASSET MANAGEMENT, LLC1.54%0.01%711,248144,53525.50%20,348,805Jun 30, 2024
JANUS HENDERSON GROUP PLC1.51%0.01%698,38896,32816.00%19,980,647Jun 30, 2024
SCHRODER INVESTMENT MANAGEMENT GROUP1.34%0.02%616,83211,6811.93%17,647,564Jun 30, 2024
ABRDN PLC1.32%0.03%609,35164,43311.82%17,433,532Jun 30, 2024
JPMORGAN CHASE & CO1.30%0.00%600,611515,539606.00%17,183,481Jun 30, 2024

Pacira BioSciences's largest institutional shareholder is BLACKROCK INC., holding 17.34% of the company's total share outstanding, currently valued at $229.08M. The top 10 institutional shareholders own together 58.30% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
DOMA PERPETUAL CAPITAL MANAGEMENT LLC2.17%13.28%1,000,761275,12637.92%28,631,772Jun 30, 2024
GAGNON SECURITIES LLC1.29%3.84%596,59147,6238.68%17,068,469Jun 30, 2024
SIO CAPITAL MANAGEMENT, LLC0.99%3.53%455,500343,500306.70%13,031,855Jun 30, 2024
GAGNON ADVISORS, LLC0.29%2.91%133,390--3,816,288Jun 30, 2024
ALPHACENTRIC ADVISORS LLC0.25%2.48%117,500--3,361,675Jun 30, 2024
ARDSLEY ADVISORY PARTNERS LP1.26%2.44%580,00086,60017.55%16,593,800Jun 30, 2024
RICE HALL JAMES & ASSOCIATES, LLC2.16%1.71%998,625-44,915-4.30%28,570,661Jun 30, 2024
LISANTI CAPITAL GROWTH, LLC0.30%0.95%138,830138,830100.00%3,971,926Jun 30, 2024
BRIDGE CITY CAPITAL, LLC0.18%0.82%84,85622,91236.99%2,427,730Jun 30, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP1.70%0.68%785,000-270,500-25.63%22,458,850Jun 30, 2024
ARDSLEY ADVISORY PARTNERS LP0.35%0.67%160,000160,000100.00%4,577,600Jun 30, 2024
VESTAL POINT CAPITAL, LP0.61%0.60%280,000200,000250.00%8,010,800Jun 30, 2024
TRIBUTARY CAPITAL MANAGEMENT, LLC0.54%0.60%251,2884200.17%7,189,350Jun 30, 2024
KETTLE HILL CAPITAL MANAGEMENT, LLC0.17%0.56%77,59877,598100.00%2,220,079Jun 30, 2024
STEPHENS INVESTMENT MANAGEMENT GROUP LLC2.97%0.55%1,371,561-55,184-3.87%39,240,360Jun 30, 2024
FRONTIER CAPITAL MANAGEMENT CO LLC3.98%0.52%1,836,873-77,470-4.05%52,552,940Jun 30, 2024
OUTFITTER FINANCIAL LLC0.04%0.48%20,1901,0955.73%577,636Jun 30, 2024
HAP TRADING, LLC0.25%0.39%115,4482,5812.29%3,302,967Jun 30, 2024
PORTOLAN CAPITAL MANAGEMENT, LLC0.29%0.31%131,901131,901100.00%3,773,688Jun 30, 2024
EASTERLY INVESTMENT PARTNERS LLC0.23%0.27%105,55626,23533.07%3,019,957Jun 30, 2024

The largest Pacira BioSciences shareholder by % of total assets is DOMA PERPETUAL CAPITAL MANAGEMENT LLC. The company owns 1.00M shares of Pacira BioSciences (PCRX), representing 13.28% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
PACER ADVISORS, INC.4.68%0.14%2,162,787590,08237.52%61,877,336Jun 30, 2024
JPMORGAN CHASE & CO1.30%0.00%600,611515,539606.00%17,183,481Jun 30, 2024
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/1.00%0.09%462,768462,768100.00%13,239,792Jun 30, 2024
CAPTION MANAGEMENT, LLC1.08%0.22%500,000378,000309.84%14,305,000Jun 30, 2024
BARCLAYS PLC0.91%0.00%421,255361,479604.72%12,053,000Jun 30, 2024
SIO CAPITAL MANAGEMENT, LLC0.99%3.53%455,500343,500306.70%13,031,855Jun 30, 2024
DOMA PERPETUAL CAPITAL MANAGEMENT LLC2.17%13.28%1,000,761275,12637.92%28,631,772Jun 30, 2024
D. E. SHAW & CO., INC.1.04%0.01%480,430239,99199.81%13,745,102Jun 30, 2024
NORGES BANK0.45%0.00%210,057210,057100.00%6,009,731Jun 30, 2024
VESTAL POINT CAPITAL, LP0.61%0.60%280,000200,000250.00%8,010,800Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP3.96%0.01%1,828,065198,93612.21%52,299,570Jun 30, 2024
WELLINGTON MANAGEMENT GROUP LLP1.05%0.00%487,135193,90366.13%13,936,933Jun 30, 2024
THORNBURG INVESTMENT MANAGEMENT INC0.41%0.08%188,590188,590100.00%5,395,560Jun 30, 2024
ROYAL BANK OF CANADA0.46%0.00%213,481188,089740.74%6,107,000Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC4.47%0.10%2,066,197184,0009.78%59,113,896Jun 30, 2024
BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC0.39%0.04%178,396178,396100.00%5,103,910Jun 30, 2024
ARDSLEY ADVISORY PARTNERS LP0.35%0.67%160,000160,000100.00%4,577,600Jun 30, 2024
MARSHALL WACE, LLP2.10%0.04%971,143159,79119.69%27,784,403Jun 30, 2024
NUVEEN ASSET MANAGEMENT, LLC1.54%0.01%711,248144,53525.50%20,348,805Jun 30, 2024
TREXQUANT INVESTMENT LP0.36%0.07%166,972142,968595.60%4,777,069Jun 30, 2024

As of Jun 30 2024, Pacira BioSciences's largest institutional buyer is PACER ADVISORS, INC.. The company purchased 590.08K stocks of PCRX, valued at $61.88M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CLEARBRIDGE INVESTMENTS, LLC----1,172,150-100.00%-Jun 30, 2024
ARCHON CAPITAL MANAGEMENT LLC----536,525-100.00%-Jun 30, 2024
ROCK SPRINGS CAPITAL MANAGEMENT LP1.70%0.68%785,000-270,500-25.63%22,458,850Jun 30, 2024
BAILLIE GIFFORD & CO1.75%0.02%806,097-194,677-19.45%23,062,435Jun 30, 2024
CANDRIAM S.C.A.----181,901-100.00%-Jun 30, 2024
MORGAN STANLEY1.12%0.00%516,165-154,162-23.00%14,767,479Jun 30, 2024
NEUMEIER POMA INVESTMENT COUNSEL LLC----151,810-100.00%-Jun 30, 2024
CLEARLINE CAPITAL LP----136,658-100.00%-Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----134,282-100.00%-Jun 30, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC0.14%0.01%64,667-123,777-65.68%1,850,123Jun 30, 2024
UBS GROUP AG0.14%0.00%65,658-99,803-60.32%1,878,475Jun 30, 2024
PROSIGHT MANAGEMENT, LP----94,362-100.00%-Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/0.54%0.00%249,144-82,876-24.96%7,129,000Jun 30, 2024
FRONTIER CAPITAL MANAGEMENT CO LLC3.98%0.52%1,836,873-77,470-4.05%52,552,940Jun 30, 2024
ASSENAGON ASSET MANAGEMENT S.A.0.29%0.01%133,458-62,837-32.01%3,818,233Jun 30, 2024
STEPHENS INVESTMENT MANAGEMENT GROUP LLC2.97%0.55%1,371,561-55,184-3.87%39,240,360Jun 30, 2024
HILLSDALE INVESTMENT MANAGEMENT INC.0.21%0.21%95,100-50,300-34.59%2,720,811Jun 30, 2024
CAPTION MANAGEMENT, LLC----48,598-100.00%-Jun 30, 2024
RICE HALL JAMES & ASSOCIATES, LLC2.16%1.71%998,625-44,915-4.30%28,570,661Jun 30, 2024
BANK OF AMERICA CORP /DE/1.21%0.00%558,987-40,412-6.74%15,992,619Jun 30, 2024

As of Jun 30 2024, Pacira BioSciences's biggest institutional seller is CLEARBRIDGE INVESTMENTS, LLC. The company sold -1.17M shares of PCRX, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/1.00%0.09%462,768462,768100.00%13,239,792Jun 30, 2024
NORGES BANK0.45%0.00%210,057210,057100.00%6,009,731Jun 30, 2024
THORNBURG INVESTMENT MANAGEMENT INC0.41%0.08%188,590188,590100.00%5,395,560Jun 30, 2024
BRANDYWINE GLOBAL INVESTMENT MANAGEMENT, LLC0.39%0.04%178,396178,396100.00%5,103,910Jun 30, 2024
LISANTI CAPITAL GROWTH, LLC0.30%0.95%138,830138,830100.00%3,971,926Jun 30, 2024
BANCO SANTANDER, S.A.0.30%0.05%138,373138,373100.00%3,958,852Jun 30, 2024
PORTOLAN CAPITAL MANAGEMENT, LLC0.29%0.31%131,901131,901100.00%3,773,688Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.28%0.01%129,191129,191100.00%3,696,155Jun 30, 2024
WINTON GROUP LTD0.21%0.18%95,26695,266100.00%2,725,560Jun 30, 2024
KETTLE HILL CAPITAL MANAGEMENT, LLC0.17%0.56%77,59877,598100.00%2,220,079Jun 30, 2024
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP0.12%0.00%53,40953,409100.00%1,528,000Jun 30, 2024
MONASHEE INVESTMENT MANAGEMENT LLC0.09%0.15%40,00040,000100.00%1,144,400Jun 30, 2024
HENNION & WALSH ASSET MANAGEMENT, INC.0.08%0.05%35,45035,450100.00%1,014,224Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.06%0.00%26,61226,612100.00%761,369Jun 30, 2024
WOLVERINE ASSET MANAGEMENT LLC0.06%0.01%25,70025,700100.00%735,277Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.05%0.00%25,00025,000100.00%715,250Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.05%0.00%22,77822,778100.00%651,679Jun 30, 2024
TOROSO INVESTMENTS, LLC0.05%0.01%21,84521,845100.00%624,985Jun 30, 2024
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)0.04%0.01%17,06217,062100.00%488,144Jun 30, 2024
GUGGENHEIM CAPITAL LLC0.04%0.00%16,85516,855100.00%482,222Jun 30, 2024
SHERBROOKE PARK ADVISERS LLC0.04%0.08%16,33716,337100.00%467,402Jun 30, 2024
LSV ASSET MANAGEMENT0.03%0.00%16,13316,133100.00%462,000Jun 30, 2024
CHOREO, LLC0.02%0.01%10,40210,402100.00%296,041Jun 30, 2024
FRANKLIN RESOURCES INC0.02%0.00%9,2589,258100.00%264,871Jun 30, 2024
MML INVESTORS SERVICES, LLC0.02%0.00%8,2818,281100.00%237,000Jun 30, 2024
RIVERWATER PARTNERS LLC0.02%0.16%7,7657,765100.00%222,157Jun 30, 2024
AMUNDI0.02%0.00%6,9726,972100.00%151,014Jun 30, 2024
CANADA PENSION PLAN INVESTMENT BOARD0.01%0.00%4,9004,900100.00%140,189Jun 30, 2024
CENTRAL PACIFIC BANK - TRUST DIVISION0.01%0.01%4,2684,268100.00%122,107Jun 30, 2024
INNEALTA CAPITAL, LLC0.00%0.02%1,7491,749100.00%50,039Jun 30, 2024
PARK PLACE CAPITAL CORP0.00%0.01%1,6001,600100.00%45,776Jun 30, 2024
1620 INVESTMENT ADVISORS, INC.0.00%0.01%588588100.00%16,823Jun 30, 2024
RALEIGH CAPITAL MANAGEMENT INC.0.00%0.01%537537100.00%15,364Jun 30, 2024
SMARTLEAF ASSET MANAGEMENT LLC0.00%0.00%267267100.00%7,451Jun 30, 2024
QUARRY LP0.00%0.00%252252100.00%7,210Jun 30, 2024
COPPELL ADVISORY SOLUTIONS LLC0.00%0.00%5858100.00%1,659Jun 30, 2024
STEPHENS CONSULTING, LLC0.00%0.00%4949100.00%1,402Jun 30, 2024
SRS CAPITAL ADVISORS, INC.0.00%0.00%4242100.00%1,202Jun 30, 2024
RONALD BLUE TRUST, INC.0.00%-3333100.00%964Jun 30, 2024
TRIAD WEALTH PARTNERS, LLC0.00%0.00%2727100.00%772Jun 30, 2024
SWAN CAPITAL LLC0.00%0.00%2727100.00%772Jun 30, 2024
LARSON FINANCIAL GROUP LLC--55100.00%143Jun 30, 2024

Pacira BioSciences's largest new institutional shareholder by number of shares is FORT WASHINGTON INVESTMENT ADVISORS INC /OH/, purchased 462.77K shares, valued at $13.24M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
CLEARBRIDGE INVESTMENTS, LLC----1,172,150-100.00%-Jun 30, 2024
ARCHON CAPITAL MANAGEMENT LLC----536,525-100.00%-Jun 30, 2024
CANDRIAM S.C.A.----181,901-100.00%-Jun 30, 2024
NEUMEIER POMA INVESTMENT COUNSEL LLC----151,810-100.00%-Jun 30, 2024
CLEARLINE CAPITAL LP----136,658-100.00%-Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC----134,282-100.00%-Jun 30, 2024
PROSIGHT MANAGEMENT, LP----94,362-100.00%-Jun 30, 2024
CAPTION MANAGEMENT, LLC----48,598-100.00%-Jun 30, 2024
MILLENNIUM MANAGEMENT LLC----37,448-100.00%-Jun 30, 2024
RAYMOND JAMES & ASSOCIATES----30,175-100.00%-Jun 30, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP----26,643-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----24,605-100.00%-Jun 30, 2024
TUDOR INVESTMENT CORP ET AL----23,244-100.00%-Jun 30, 2024
GSA CAPITAL PARTNERS LLP----22,722-100.00%-Jun 30, 2024
TEJARA CAPITAL LTD----20,000-100.00%-Jun 30, 2024
NEW YORK LIFE INVESTMENT MANAGEMENT LLC----12,507-100.00%-Jun 30, 2024
AZZAD ASSET MANAGEMENT INC /ADV----9,384-100.00%-Jun 30, 2024
DANA INVESTMENT ADVISORS, INC.----9,345-100.00%-Jun 30, 2024
ENTRYPOINT CAPITAL, LLC----8,335-100.00%-Jun 30, 2024
BREVAN HOWARD CAPITAL MANAGEMENT LP----7,395-100.00%-Jun 30, 2024
DYNAMIC TECHNOLOGY LAB PRIVATE LTD----7,172-100.00%-Jun 30, 2024
PALOMA PARTNERS MANAGEMENT CO----7,151-100.00%-Jun 30, 2024
WALLEYE TRADING LLC----5,300-100.00%-Jun 30, 2024
STEPHENS INC /AR/----4,940-100.00%-Jun 30, 2024
QUANTBOT TECHNOLOGIES LP----4,892-100.00%-Jun 30, 2024
WALLEYE CAPITAL LLC----4,400-100.00%-Jun 30, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.----3,987-100.00%-Jun 30, 2024
METROPOLITAN LIFE INSURANCE CO/NY----2,422-100.00%-Jun 30, 2024
SIMPLEX TRADING, LLC----2,281-100.00%-Jun 30, 2024
APOLLO MANAGEMENT HOLDINGS, L.P.----2,114-100.00%-Jun 30, 2024
FIDELIS CAPITAL PARTNERS, LLC----506-100.00%-Jun 30, 2024
HEADLANDS TECHNOLOGIES LLC----463-100.00%-Jun 30, 2024
EVERSOURCE WEALTH ADVISORS, LLC----247-100.00%-Jun 30, 2024
PARALLEL ADVISORS, LLC----223-100.00%-Jun 30, 2024
ORION CAPITAL MANAGEMENT LLC----200-100.00%-Jun 30, 2024
HARBOR INVESTMENT ADVISORY, LLC----38-100.00%-Jun 30, 2024
CORECAP ADVISORS, LLC----16-100.00%-Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----9-100.00%-Jun 30, 2024
PRAIRIEVIEW PARTNERS, LLC----5-100.00%-Jun 30, 2024

Pacira BioSciences's largest sold out institutional shareholder by shares sold is CLEARBRIDGE INVESTMENTS, LLC, sold -1.17M shares, valued at -, as of undefined.

Pacira BioSciences Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VOYAGEUR MUTUAL FUNDS III7.64%75,296--Jan 31, 2024
Manager Directed Portfolios2.43%398,313--Jan 31, 2024
DELAWARE INVESTMENTS DIVIDEND & INCOME FUND, INC0.58%152,000152,000-Feb 28, 2023
DELAWARE GROUP EQUITY FUNDS IV0.55%638,000--Mar 28, 2024
GABELLI CONVERTIBLE & INCOME SECURITIES FUND INC0.53%418,000--Dec 29, 2023
NICHOLAS Ltd EDITION, INC.0.46%152,350--Dec 31, 2023
BANCROFT FUND LTD0.45%627,000--Dec 29, 2023
ELLSWORTH GROWTH & INCOME FUND LTD0.45%629,000--Dec 29, 2023
Virtus Strategy Trust0.39%8,245,000--Mar 28, 2024
Virtus Diversified Income & Convertible Fund0.32%650,000--Jan 31, 2024
HARTFORD HLS SERIES FUND II INC0.32%77,939--Dec 31, 2023
Delaware Enhanced Global Dividend & Income Fund0.24%89,00089,000-Feb 28, 2023
TETON WESTWOOD FUNDS0.16%104,000--Dec 29, 2023
Voya EQUITY TRUST0.11%160,947--Feb 29, 2024
Federated Hermes MDT Series0.11%269,322-41,280-13.29%Jan 31, 2024
Voya VARIABLE PRODUCTS TRUST0.09%31,530--Mar 31, 2024
M FUND INC0.08%37,866-573-1.49%Mar 31, 2024
NUVEEN INVESTMENT TRUST0.07%41,822--Mar 31, 2024
DEUTSCHE DWS INVESTMENT TRUST0.07%226,241--Mar 31, 2024
ALLSPRING VARIABLE TRUST0.07%43,800--Mar 31, 2024
VANGUARD ADMIRAL FUNDS0.07%305,25662,56425.78%Feb 29, 2024
T. Rowe Price Quantitative Management Funds, Inc.0.07%211,000-49,100-18.88%Mar 31, 2024
VANGUARD VALLEY FORGE FUNDS0.06%31,254--Mar 31, 2024
PRUDENTIAL JENNISON SMALL CO FUND, INC.0.06%256,009--Mar 28, 2024
VANGUARD EXPLORER FUND0.05%653,82023,4693.72%Jan 31, 2024
BNY MELLON INDEX FUNDS, INC.0.04%47,539-6,035-11.26%Jan 31, 2024
HIGHLAND FUNDS II0.04%631--Dec 31, 2023
DEUTSCHE DWS VARIABLE SERIES I0.04%15,229--Mar 31, 2024
Voya PARTNERS INC0.04%3,240,000--Mar 31, 2024
BNY MELLON INVESTMENT PORTFOLIOS0.04%22,835-555-2.37%Mar 31, 2024
DELAWARE GROUP EQUITY FUNDS V0.04%2,265,000--Feb 29, 2024
TOCQUEVILLE TRUST0.04%5,000--Jan 31, 2024
SYNTAX ETF TRUST0.04%1,120-215-16.10%Mar 31, 2024
PRUDENTIAL JENNISON BLEND FUND, INC.0.04%21,740--Feb 29, 2024
GLENMEDE FUND INC0.03%305,888-8,845-2.81%Jan 31, 2024
Tributary Funds, Inc.0.03%168,75451,13343.47%Dec 31, 2023
DELAWARE GROUP EQUITY FUNDS IV0.03%31,938--Mar 28, 2024
Pacer Funds Trust0.03%1,219,0671,218,805465192.75%Jan 31, 2024
Humankind Benefit Corp0.02%55314234.55%Dec 31, 2023
DELAWARE GROUP EQUITY FUNDS V0.02%1,306,316192,52417.29%Feb 29, 2024
LEGG MASON PARTNERS VARIABLE EQUITY TRUST0.02%85,252--Dec 29, 2023
VALUED ADVISERS TRUST0.02%19,285--Jan 31, 2024
DELAWARE VIP TRUST0.02%69,000-46,000-40.00%Mar 28, 2024
AMG Funds I0.02%36,2389,33734.71%Jan 31, 2024
LEGG MASON PARTNERS INVESTMENT TRUST0.02%900,693-9,122-1.00%Jan 31, 2024
ALGER INSTITUTIONAL FUNDS0.01%3,445--Jan 31, 2024
Vericimetry Funds0.01%1,1801,180-Mar 31, 2024
PAX WORLD FUNDS SERIES TRUST I0.01%260,02760,00030.00%Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.01%80,010-3,822-4.56%Mar 31, 2024
abrdn Funds0.01%166,74031,75423.52%Jan 31, 2024
Voya PARTNERS INC0.01%936,000--Mar 31, 2024
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.01%6,648-248-3.60%Mar 31, 2024
ALGER FUNDS0.01%10,526--Jan 31, 2024
HARBOR FUNDS0.01%246,621--Jan 31, 2024
BNY Mellon Strategic Funds, Inc.0.01%23,050-7,143-23.66%Feb 29, 2024
VANGUARD INDEX FUNDS0.01%3,843,863-660,249-14.66%Mar 31, 2024
360 Funds0.01%1,561--Feb 29, 2024
AIM GROWTH SERIES (INVESCO GROWTH SERIES)0.01%227,722--Mar 31, 2024
TIAA SEPARATE ACCOUNT VA 10.01%1,343--Mar 31, 2024
HUSSMAN INVESTMENT TRUST0.01%21,000-5,000-19.23%Dec 31, 2023
FIRST TRUST EXCHANGE-TRADED FUND IV0.01%1,250,000--Jan 31, 2024
DRIEHAUS MUTUAL FUNDS0.01%48,051--Mar 28, 2024
Innovator ETFs Trust0.01%21,985--Jan 31, 2024
RANGER FUNDS INVESTMENT TRUST0.01%199199-Apr 30, 2020
DEUTSCHE DWS VARIABLE SERIES II0.00%11,807--Mar 31, 2024
FIDELITY COMMONWEALTH TRUST0.00%15,1812481.66%Feb 29, 2024
JNL VARIABLE FUND LLC0.00%25,889-2,522-8.88%Mar 31, 2020
STEWARD FUNDS, INC.0.00%10,7557717.72%Jan 31, 2024
CLEARWATER INVESTMENT TRUST0.00%42,287-840-1.95%Mar 28, 2024
Guggenheim Variable Funds Trust0.00%17,891--Dec 31, 2023
FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND0.00%16,6396694.19%Jan 31, 2024
AMERICAN CENTURY QUANTITATIVE EQUITY FUNDS, INC.0.00%9,876--Mar 31, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%341,68457,49320.23%Jan 31, 2024
Securian Funds Trust0.00%38,429--Mar 31, 2024
James Alpha Funds Trust0.00%25,700--Feb 29, 2024
BRIDGEWAY FUNDS INC0.00%8,300--Mar 28, 2024
IndexIQ ETF Trust0.00%7,967-562-6.59%Jan 31, 2024
Voya PARTNERS INC0.00%263,000--Mar 31, 2024
Federated Hermes Equity Funds0.00%60,881--Mar 31, 2024
WESMARK FUNDS0.00%10,503--Mar 31, 2024
SCHWAB CAPITAL TRUST0.00%125,022-1,164-0.92%Jan 31, 2024
Virtus Investment Trust0.00%97,664-13,531-12.17%Mar 28, 2024
FINANCIAL INVESTORS TRUST0.00%215,107--Jan 31, 2024
ROYCE VALUE TRUST, INC.0.00%2,158--Mar 31, 2024
EXCHANGE TRADED CONCEPTS TRUST0.00%15,092850.57%Feb 29, 2024
Segall Bryant & Hamill Trust0.00%46,547--Mar 31, 2024
FIRST TRUST EXCHANGE-TRADED FUND IV0.00%565,000--Jan 31, 2024
NUVEEN INVESTMENT FUNDS INC0.00%80,470--Jan 31, 2024
Ivy Variable Insurance Portfolios0.00%53,925--Mar 28, 2024
DEUTSCHE DWS GLOBAL/INTERNATIONAL FUND, INC.0.00%4,969--Mar 31, 2024
Columbia Funds Variable Series Trust II0.00%72,199-4,081-5.35%Mar 31, 2024
FIDELITY CONCORD STREET TRUST0.00%435,81617,1144.09%Feb 29, 2024
Principal Exchange-Traded Funds0.00%23,6342,1079.79%Mar 31, 2024
Legg Mason ETF Investment Trust0.00%3,7951,05038.25%Mar 31, 2024
Franklin Alternative Strategies Funds0.00%1,056,000115,00012.22%Feb 29, 2024
PFM Multi-Manager Series Trust0.00%1,535--Dec 31, 2023
SHP ETF Trust0.00%6,432--Feb 29, 2024
JANUS INVESTMENT FUND0.00%561,32169,33814.09%Dec 31, 2023
VANGUARD TAX-MANAGED FUNDS0.00%356,312-6,483-1.79%Mar 31, 2024
Calvert Variable Products, Inc.0.00%4,526--Mar 31, 2024

Pacira BioSciences's largest mutual fund holder by % of total assets is "VOYAGEUR MUTUAL FUNDS III", owning 75.30K shares, compromising 7.64% of its total assets.

Pacira BioSciences Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 242831.07%
31 Mar, 242804.87%
31 Dec, 232671.52%
30 Sep, 232631.15%
30 Jun, 23260-5.11%
31 Mar, 23274-
31 Dec, 222742.24%
30 Sep, 22268-6.62%
30 Jun, 22287-4.97%
31 Mar, 2230211.03%
31 Dec, 212724.21%
30 Sep, 21261-1.14%
30 Jun, 21264-3.30%
31 Mar, 212731.87%
31 Dec, 202682.29%
30 Sep, 202623.56%
30 Jun, 202538.12%
31 Mar, 20234-2.09%
31 Dec, 192395.29%
30 Sep, 19227-3.81%
30 Jun, 192367.27%
31 Mar, 192200.92%
31 Dec, 182185.83%
30 Sep, 1820623.35%
30 Jun, 18167-8.24%
31 Mar, 18182-9.45%
31 Dec, 172012.03%
30 Sep, 17197-6.64%
30 Jun, 17211-2.76%
31 Mar, 172177.43%
31 Dec, 162021.51%
30 Sep, 161990.51%
30 Jun, 16198-0.50%
31 Mar, 16199-11.56%
31 Dec, 1522519.68%
30 Sep, 15188-4.57%
30 Jun, 15197-8.37%
31 Mar, 152153.37%
31 Dec, 14208-4.59%
30 Sep, 142187.92%
30 Jun, 1420218.82%
31 Mar, 1417021.43%
31 Dec, 13140-
30 Sep, 1314013.82%
30 Jun, 13123161.70%
31 Mar, 134734.29%
31 Dec, 12352.94%
30 Sep, 12346.25%
30 Jun, 123288.24%
31 Mar, 1217-
31 Dec, 111721.43%
30 Sep, 111427.27%
30 Jun, 1111175.00%
31 Mar, 114-

As of 30 Jun 24, 283 institutions are holding Pacira BioSciences's shares, representing an increase of 1.07% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2451,801,8195.53%
31 Mar, 2449,086,7051.55%
31 Dec, 2348,335,7792.87%
30 Sep, 2346,987,5340.16%
30 Jun, 2346,910,1561.29%
31 Mar, 2346,311,567-4.14%
31 Dec, 2248,311,177-3.53%
30 Sep, 2250,076,8852.47%
30 Jun, 2248,870,176-1.40%
31 Mar, 2249,564,578-1.97%
31 Dec, 2150,561,1162.91%
30 Sep, 2149,132,493-0.46%
30 Jun, 2149,360,450-0.93%
31 Mar, 2149,821,382-1.15%
31 Dec, 2050,400,7994.20%
30 Sep, 2048,367,998-0.68%
30 Jun, 2048,700,5983.58%
31 Mar, 2047,018,0003.43%
31 Dec, 1945,460,2240.75%
30 Sep, 1945,123,5475.45%
30 Jun, 1942,790,1713.40%
31 Mar, 1941,384,0311.84%
31 Dec, 1840,638,113-0.65%
30 Sep, 1840,904,247-4.63%
30 Jun, 1842,890,751-1.64%
31 Mar, 1843,607,5224.09%
31 Dec, 1741,894,425-4.23%
30 Sep, 1743,743,4266.16%
30 Jun, 1741,206,8450.24%
31 Mar, 1741,108,0932.08%
31 Dec, 1640,271,8471.23%
30 Sep, 1639,781,785-2.38%
30 Jun, 1640,750,842-6.79%
31 Mar, 1643,721,0501.74%
31 Dec, 1542,972,1120.20%
30 Sep, 1542,887,0500.18%
30 Jun, 1542,809,1726.08%
31 Mar, 1540,354,1682.83%
31 Dec, 1439,242,3841.21%
30 Sep, 1438,774,1102.53%
30 Jun, 1437,818,9867.23%
31 Mar, 1435,268,9172.52%
31 Dec, 1334,403,004-2.85%
30 Sep, 1335,412,4222.91%
30 Jun, 1334,409,716101.61%
31 Mar, 1317,067,8086.33%
31 Dec, 1216,051,2826.97%
30 Sep, 1215,005,146-4.97%
30 Jun, 1215,789,08087.05%
31 Mar, 128,440,900-4.31%
31 Dec, 118,821,017112.30%
30 Sep, 114,154,933-7.28%
30 Jun, 114,481,2985.72%
31 Mar, 114,238,991-

Pacira BioSciences (PCRX) has 51.80M shares outstanding as of 30 Jun 24, up 5.53% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 24112.19%1.01%
31 Mar, 24105.57%0.97%
31 Dec, 23104.09%1.02%
30 Sep, 23101.23%0.98%
30 Jun, 23101.78%1.00%
31 Mar, 23100.79%0.89%
31 Dec, 22106.13%0.89%
30 Sep, 22109.26%1.14%
30 Jun, 2297.99%0.80%
31 Mar, 22110.47%0.86%
31 Dec, 21113.38%0.93%
30 Sep, 21110.47%0.88%
30 Jun, 21111.81%0.87%
31 Mar, 21113.66%0.85%
31 Dec, 20115.86%0.91%
30 Sep, 20112.67%0.85%
30 Jun, 20115.35%0.92%
31 Mar, 20111.86%0.90%
31 Dec, 19111.18%0.90%
30 Sep, 19111.20%1.04%
30 Jun, 19103.40%0.95%
31 Mar, 19104.54%1.06%
31 Dec, 1899.33%1.00%
30 Sep, 1899.78%0.90%
30 Jun, 18105.13%0.92%
31 Mar, 18107.13%0.97%
31 Dec, 17105.25%0.90%
30 Sep, 17108.11%1.03%
30 Jun, 17102.61%0.88%
31 Mar, 17108.18%0.92%
31 Dec, 16108.24%0.95%
30 Sep, 16106.62%0.89%
30 Jun, 16109.60%0.79%
31 Mar, 16118.10%0.85%
31 Dec, 15117.60%0.86%
30 Sep, 15116.98%0.85%
30 Jun, 15117.35%0.95%
31 Mar, 15111.37%0.94%
31 Dec, 14108.77%0.93%
30 Sep, 14107.88%0.95%
30 Jun, 14106.64%0.97%
31 Mar, 14104.62%1.00%
31 Dec, 13102.47%0.91%
30 Sep, 13106.15%0.98%
30 Jun, 13104.01%3.82%
31 Mar, 1352.18%1.86%
31 Dec, 1252.92%2.43%
30 Sep, 1246.70%1.79%
30 Jun, 1251.01%4.61%
31 Mar, 1233.27%2.75%
31 Dec, 1134.77%5.98%
30 Sep, 1124.11%3.57%
30 Jun, 1126.00%1.45%
31 Mar, 1142.33%-

As of 30 Jun 24, Pacira BioSciences is held by 112.19% institutional shareholders, representing a 1.01% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2415313.33%
31 Mar, 241354.65%
31 Dec, 23129-3.73%
30 Sep, 231343.08%
30 Jun, 23130-12.16%
31 Mar, 231484.23%
31 Dec, 221429.23%
30 Sep, 22130-9.09%
30 Jun, 22143-13.33%
31 Mar, 2216515.38%
31 Dec, 2114317.21%
30 Sep, 211224.27%
30 Jun, 211170.86%
31 Mar, 21116-15.33%
31 Dec, 201372.24%
30 Sep, 20134-6.94%
30 Jun, 2014422.03%
31 Mar, 201180.85%
31 Dec, 191170.86%
30 Sep, 19116-7.20%
30 Jun, 191258.70%
31 Mar, 191154.55%
31 Dec, 181107.84%
30 Sep, 1810230.77%
30 Jun, 1878-11.36%
31 Mar, 1888-21.43%
31 Dec, 171125.66%
30 Sep, 17106-7.02%
30 Jun, 17114-2.56%
31 Mar, 1711721.88%
31 Dec, 1696-4.95%
30 Sep, 16101-14.41%
30 Jun, 1611811.32%
31 Mar, 16106-20.90%
31 Dec, 1513424.07%
30 Sep, 151086.93%
30 Jun, 15101-15.13%
31 Mar, 1511913.33%
31 Dec, 14105-13.22%
30 Sep, 141214.31%
30 Jun, 1411619.59%
31 Mar, 149744.78%
31 Dec, 1367-14.10%
30 Sep, 1378-17.89%
30 Jun, 1395150.00%
31 Mar, 133858.33%
31 Dec, 1224-
30 Sep, 1224-20.00%
30 Jun, 1230200.00%
31 Mar, 1210-37.50%
31 Dec, 1116100.00%
30 Sep, 118-
30 Jun, 118100.00%
31 Mar, 114-

153 institutional shareholders have increased their position in PCRX stock as of 30 Jun 24 compared to 135 in the previous quarter (a 13.33% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 2476-9.52%
31 Mar, 2484-5.62%
31 Dec, 23895.95%
30 Sep, 2384-7.69%
30 Jun, 23919.64%
31 Mar, 2383-8.79%
31 Dec, 229113.75%
30 Sep, 2280-23.08%
30 Jun, 2210414.29%
31 Mar, 229110.98%
31 Dec, 2182-5.75%
30 Sep, 21874.82%
30 Jun, 2183-18.63%
31 Mar, 2110224.39%
31 Dec, 2082-2.38%
30 Sep, 208418.31%
30 Jun, 2071-
31 Mar, 2071-2.74%
31 Dec, 197317.74%
30 Sep, 19625.08%
30 Jun, 1959-9.23%
31 Mar, 1965-12.16%
31 Dec, 187419.35%
30 Sep, 186214.81%
30 Jun, 1854-10.00%
31 Mar, 186013.21%
31 Dec, 175315.22%
30 Sep, 1746-20.69%
30 Jun, 1758-9.38%
31 Mar, 17646.67%
31 Dec, 166013.21%
30 Sep, 165312.77%
30 Jun, 1647-22.95%
31 Mar, 1661-1.61%
31 Dec, 156224.00%
30 Sep, 1550-23.08%
30 Jun, 1565-7.14%
31 Mar, 1570-9.09%
31 Dec, 147714.93%
30 Sep, 146728.85%
30 Jun, 145210.64%
31 Mar, 1447-9.62%
31 Dec, 135218.18%
30 Sep, 1344175.00%
30 Jun, 1316166.67%
31 Mar, 136-40.00%
31 Dec, 121042.86%
30 Sep, 127250.00%
30 Jun, 122-66.67%
31 Mar, 126500.00%
31 Dec, 111-80.00%
30 Sep, 115150.00%
30 Jun, 112-
31 Mar, 11--

76 institutional shareholders have reduced their position in PCRX stock as of 30 Jun 24 compared to 84 in the previous quarter (a -9.52% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 242831.07%51,801,8195.53%112.19%1.01%15313.33%76-9.52%
31 Mar, 242804.87%49,086,7051.55%105.57%0.97%1354.65%84-5.62%
31 Dec, 232671.52%48,335,7792.87%104.09%1.02%129-3.73%895.95%
30 Sep, 232631.15%46,987,5340.16%101.23%0.98%1343.08%84-7.69%
30 Jun, 23260-5.11%46,910,1561.29%101.78%1.00%130-12.16%919.64%
31 Mar, 23274-46,311,567-4.14%100.79%0.89%1484.23%83-8.79%
31 Dec, 222742.24%48,311,177-3.53%106.13%0.89%1429.23%9113.75%
30 Sep, 22268-6.62%50,076,8852.47%109.26%1.14%130-9.09%80-23.08%
30 Jun, 22287-4.97%48,870,176-1.40%97.99%0.80%143-13.33%10414.29%
31 Mar, 2230211.03%49,564,578-1.97%110.47%0.86%16515.38%9110.98%
31 Dec, 212724.21%50,561,1162.91%113.38%0.93%14317.21%82-5.75%
30 Sep, 21261-1.14%49,132,493-0.46%110.47%0.88%1224.27%874.82%
30 Jun, 21264-3.30%49,360,450-0.93%111.81%0.87%1170.86%83-18.63%
31 Mar, 212731.87%49,821,382-1.15%113.66%0.85%116-15.33%10224.39%
31 Dec, 202682.29%50,400,7994.20%115.86%0.91%1372.24%82-2.38%
30 Sep, 202623.56%48,367,998-0.68%112.67%0.85%134-6.94%8418.31%
30 Jun, 202538.12%48,700,5983.58%115.35%0.92%14422.03%71-
31 Mar, 20234-2.09%47,018,0003.43%111.86%0.90%1180.85%71-2.74%
31 Dec, 192395.29%45,460,2240.75%111.18%0.90%1170.86%7317.74%
30 Sep, 19227-3.81%45,123,5475.45%111.20%1.04%116-7.20%625.08%
30 Jun, 192367.27%42,790,1713.40%103.40%0.95%1258.70%59-9.23%
31 Mar, 192200.92%41,384,0311.84%104.54%1.06%1154.55%65-12.16%
31 Dec, 182185.83%40,638,113-0.65%99.33%1.00%1107.84%7419.35%
30 Sep, 1820623.35%40,904,247-4.63%99.78%0.90%10230.77%6214.81%
30 Jun, 18167-8.24%42,890,751-1.64%105.13%0.92%78-11.36%54-10.00%
31 Mar, 18182-9.45%43,607,5224.09%107.13%0.97%88-21.43%6013.21%
31 Dec, 172012.03%41,894,425-4.23%105.25%0.90%1125.66%5315.22%
30 Sep, 17197-6.64%43,743,4266.16%108.11%1.03%106-7.02%46-20.69%
30 Jun, 17211-2.76%41,206,8450.24%102.61%0.88%114-2.56%58-9.38%
31 Mar, 172177.43%41,108,0932.08%108.18%0.92%11721.88%646.67%
31 Dec, 162021.51%40,271,8471.23%108.24%0.95%96-4.95%6013.21%
30 Sep, 161990.51%39,781,785-2.38%106.62%0.89%101-14.41%5312.77%
30 Jun, 16198-0.50%40,750,842-6.79%109.60%0.79%11811.32%47-22.95%
31 Mar, 16199-11.56%43,721,0501.74%118.10%0.85%106-20.90%61-1.61%
31 Dec, 1522519.68%42,972,1120.20%117.60%0.86%13424.07%6224.00%
30 Sep, 15188-4.57%42,887,0500.18%116.98%0.85%1086.93%50-23.08%
30 Jun, 15197-8.37%42,809,1726.08%117.35%0.95%101-15.13%65-7.14%
31 Mar, 152153.37%40,354,1682.83%111.37%0.94%11913.33%70-9.09%
31 Dec, 14208-4.59%39,242,3841.21%108.77%0.93%105-13.22%7714.93%
30 Sep, 142187.92%38,774,1102.53%107.88%0.95%1214.31%6728.85%
30 Jun, 1420218.82%37,818,9867.23%106.64%0.97%11619.59%5210.64%
31 Mar, 1417021.43%35,268,9172.52%104.62%1.00%9744.78%47-9.62%
31 Dec, 13140-34,403,004-2.85%102.47%0.91%67-14.10%5218.18%
30 Sep, 1314013.82%35,412,4222.91%106.15%0.98%78-17.89%44175.00%
30 Jun, 13123161.70%34,409,716101.61%104.01%3.82%95150.00%16166.67%
31 Mar, 134734.29%17,067,8086.33%52.18%1.86%3858.33%6-40.00%
31 Dec, 12352.94%16,051,2826.97%52.92%2.43%24-1042.86%
30 Sep, 12346.25%15,005,146-4.97%46.70%1.79%24-20.00%7250.00%
30 Jun, 123288.24%15,789,08087.05%51.01%4.61%30200.00%2-66.67%
31 Mar, 1217-8,440,900-4.31%33.27%2.75%10-37.50%6500.00%
31 Dec, 111721.43%8,821,017112.30%34.77%5.98%16100.00%1-80.00%
30 Sep, 111427.27%4,154,933-7.28%24.11%3.57%8-5150.00%
30 Jun, 1111175.00%4,481,2985.72%26.00%1.45%8100.00%2-
31 Mar, 114-4,238,991-42.33%-4---

Pacira BioSciences Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 14, 2024YANG MICHAEL J.director-P-PurchaseBuy2,000$12.90$25.80K7,230
Aug 13, 2024Lee Frank D.director, officer Chief Executive OfficerP-PurchaseBuy8,264$12.10$99.99K107,784
Aug 12, 2024Froimson Markdirector-P-PurchaseBuy1,400$11.58$16.21K14,473
Aug 12, 2024BIGAL MARCELOdirector-P-PurchaseBuy3,400$12.01$40.83K8,630
Aug 02, 2024SLONIN JONATHANofficer Chief Medical OfficerS-SaleSell945$20.05$18.95K94,306
Jul 03, 2024SLONIN JONATHANofficer Chief Medical OfficerS-SaleSell2,836$28.25$80.12K95,556
Jun 13, 2024RIKER LAURENofficer Senior Vice President, FinanceS-SaleSell3,970$28.72$114.02K38,075
Jun 13, 2024SLONIN JONATHANofficer Chief Medical OfficerS-SaleSell5,012$28.57$143.19K44,569

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 14, 2024YANG MICHAEL J.director-P-PurchaseBuy2,000$12.90$25.80K7,230
Aug 13, 2024Lee Frank D.director, officer Chief Executive OfficerP-PurchaseBuy8,264$12.10$99.99K107,784
Aug 12, 2024Froimson Markdirector-P-PurchaseBuy1,400$11.58$16.21K14,473
Aug 12, 2024BIGAL MARCELOdirector-P-PurchaseBuy3,400$12.01$40.83K8,630

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 02, 2024SLONIN JONATHANofficer Chief Medical OfficerF-InKindSell305$20.75$6.33K95,251
Aug 02, 2024SLONIN JONATHANofficer Chief Medical OfficerS-SaleSell945$20.05$18.95K94,306
Jul 03, 2024SLONIN JONATHANofficer Chief Medical OfficerF-InKindSell914$28.46$26.01K98,392
Jul 03, 2024SLONIN JONATHANofficer Chief Medical OfficerS-SaleSell2,836$28.25$80.12K95,556
Jun 13, 2024RIKER LAURENofficer Senior Vice President, FinanceS-SaleSell3,970$28.72$114.02K38,075
Jun 13, 2024SLONIN JONATHANofficer Chief Medical OfficerS-SaleSell5,012$28.57$143.19K44,569

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 14, 2024YANG MICHAEL J.director-P-PurchaseBuy2,000$12.90$25.80K7,230
Aug 13, 2024Lee Frank D.director, officer Chief Executive OfficerP-PurchaseBuy8,264$12.10$99.99K107,784
Aug 12, 2024Froimson Markdirector-P-PurchaseBuy1,400$11.58$16.21K14,473
Aug 12, 2024BIGAL MARCELOdirector-P-PurchaseBuy3,400$12.01$40.83K8,630
Aug 02, 2024SLONIN JONATHANofficer Chief Medical OfficerF-InKindSell305$20.75$6.33K95,251
Aug 02, 2024SLONIN JONATHANofficer Chief Medical OfficerS-SaleSell945$20.05$18.95K94,306
Jul 03, 2024GAUGLER DARYLofficer Chief Operating OfficerA-AwardBuy160$24.32$3.90K116,199
Jul 03, 2024SLONIN JONATHANofficer Chief Medical OfficerA-AwardBuy437$24.32$10.63K99,306
Jul 03, 2024SLONIN JONATHANofficer Chief Medical OfficerF-InKindSell914$28.46$26.01K98,392
Jul 03, 2024SLONIN JONATHANofficer Chief Medical OfficerS-SaleSell2,836$28.25$80.12K95,556
Jun 13, 2024RIKER LAURENofficer Senior Vice President, FinanceA-AwardBuy21,360--42,045
Jun 13, 2024RIKER LAURENofficer Senior Vice President, FinanceS-SaleSell3,970$28.72$114.02K38,075
Jun 13, 2024SLONIN JONATHANofficer Chief Medical OfficerA-AwardBuy54,300--98,869
Jun 13, 2024SLONIN JONATHANofficer Chief Medical OfficerS-SaleSell5,012$28.57$143.19K44,569
Jun 13, 2024CHRISTIE CHRISTOPHERdirector-A-AwardBuy12,179$28.68$349.29K12,179
Jun 13, 2024CHRISTIE CHRISTOPHERdirector-A-AwardBuy5,230--10,491
Jun 13, 2024BIGAL MARCELOdirector-A-AwardBuy12,179$28.68$349.29K12,179
Jun 13, 2024BIGAL MARCELOdirector-A-AwardBuy5,230--5,230
Jun 13, 2024Reinhart Charles A. IIIofficer Chief Financial OfficerA-AwardBuy12,220--51,867
Jun 13, 2024YANG MICHAEL J.director-A-AwardBuy12,179$28.68$349.29K12,179

The last insider sell of Pacira BioSciences's stock was made by SLONIN JONATHAN on Aug 02 2024, selling 305 shares at $20.75 per share (valued at $6.33K). The last insider buy of PCRX was made by YANG MICHAEL J. on Aug 14 2024, buying 2,000 shares at $12.90 per share (worth $25.80K).

Pacira BioSciences Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 202444100.00%
Q2 20242510250.00%
Q1 202464150.00%
Q4 20234666.67%
Q3 2023-2-
Q2 2023293974.36%
Q1 2023-13-
Q4 2022-1-
Q3 2022-4-
Q2 2022444891.67%
Q1 2022284365.12%
Q4 202131717.65%
Q3 20216875.00%
Q2 20213929134.48%
Q1 202162722.22%
Q4 202052025.00%
Q3 2020153938.46%
Q2 20204227155.56%
Q1 2020121580.00%
Q4 2019152657.69%

4 total buy trades, and 4 total sell trades (buy/sell ratio of 1.00%) were made by Pacira BioSciences's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 202442200.00%
Q2 2024-5-
Q1 2024-3-
Q4 2023---
Q3 2023-2-
Q2 2023-34-
Q1 2023-2-
Q4 2022-1-
Q3 2022-4-
Q2 2022-31-
Q1 2022-17-
Q4 2021---
Q3 2021-3-
Q2 2021-22-
Q1 2021-19-
Q4 2020-11-
Q3 2020-19-
Q2 2020-20-
Q1 20201616.67%
Q4 2019-9-

As of Q3 2024, Insider owners conducted 4 open market buy trades and 2 open market sell trades of Pacira BioSciences's stocks.

Pacira BioSciences Peer Ownership


TickerCompany
HCMHUTCHMED (China) Limited
ITCIIntra-Cellular Therapies, Inc.
RDYDr. Reddy's Laboratories Limited
ANIPANI Pharmaceuticals, Inc.
PAHCPhibro Animal Health Corporation
IXHLIncannex Healthcare Limited
SSICSilver Spike Investment Corp.
DCPHDeciphera Pharmaceuticals, Inc.
PBHPrestige Consumer Healthcare Inc.
ALKSAlkermes plc
COLLCollegium Pharmaceutical, Inc.
EGRXEagle Pharmaceuticals, Inc.

PCRX Ownership FAQ


Pacira BioSciences is owned by institutional shareholders (112.19%), insiders (2.03%), and public (-14.22%). The largest institutional shareholder of Pacira BioSciences is BLACKROCK INC. (17.34% of total shares) and the top mutual fund owner is VOYAGEUR MUTUAL FUNDS III (7.64% of total shares).

Pacira BioSciences's major institutional shareholders are BLACKROCK INC., VANGUARD GROUP INC, PACER ADVISORS, INC., RENAISSANCE TECHNOLOGIES LLC, and STATE STREET CORP. The top five shareholders own together 41.63% of the company's share outstanding.

As of Jun 2024, there are 283 institutional shareholders of Pacira BioSciences.

BLACKROCK INC owns 8.01M shares of Pacira BioSciences, representing 17.34% of the company's total shares outstanding, valued at $229.08M (as of Jun 2024).

As of Jun 2024, VANGUARD GROUP INC holds 5.08M shares of Pacira BioSciences (PCRX), compromising 11.01% of the company, valued at $145.48M.

PACER ADVISORS, INC is the third largest holder of Pacira BioSciences. The company owns 2.16M of the company's shares outstanding (worth $61.88M).